$13.77B
Revenue
$2.73B
Net Income
57.00%
Gross Margin
37.45%
Op. Margin
$-13.03B
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
|---|---|---|
| Total Revenue | $13.77B | $13.77B |
| Revenue Growth % | 0.0% | nan% |
| Cost of Revenue | $5.92B | $5.92B |
| Gross Profit | $7.85B | $7.85B |
| Gross Margin % | 57.0% | 57.0% |
| Operating Expenses | $8.61B | $8.61B |
| Research & Development | $344.00M | $344.00M |
| Operating Income | $5.16B | $5.16B |
| Operating Margin % | 37.4% | 37.4% |
| Interest Expense | $1.00B | $1.00B |
| Other Income/Expense | $-1.79B | $-1.79B |
| Income Before Tax | $3.36B | $3.36B |
| Income Tax Expense | $630.00M | $630.00M |
| Net Income | $2.73B | $2.73B |
| Net Margin % | 19.8% | 19.8% |
| Basic EPS | 0.94 | 0.93 |
| Diluted EPS | 0.86 | 0.86 |
| Basic Shares Outstanding | - | 2.43B |
| Diluted Shares Outstanding | - | 2.63B |
| Breakdown | FY 2025 (Dec 31, 2025) |
|---|---|
| Cash & Cash Equivalents | $2.35B |
| Accounts Receivable | $918.00M |
| Inventory | $253.00M |
| Other Current Assets | $254.00M |
| Total Current Assets | $4.04B |
| Other Non-current Assets | $447.00M |
| Total Assets | $53.45B |
| Accounts Payable | $737.00M |
| Accrued Liabilities | $2.79B |
| Total Current Liabilities | $4.34B |
| Long-term Debt | $34.20B |
| Deferred Tax Liabilities | $2.32B |
| Other Non-current Liabilities | $697.00M |
| Total Liabilities | $41.45B |
| Retained Earnings | $4.72B |
| Total Stockholders Equity | $6.74B |
| Total Liabilities & Equity | $53.45B |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
|---|---|---|
| Net Income | $3.25B | $2.73B |
| Depreciation & Amortization | $1.16B | $941.00M |
| Stock-based Compensation | $81.00M | $46.00M |
| Deferred Income Tax | - | $640.00M |
| Change in Receivables | $1.16B | $564.00M |
| Change in Inventory | $94.00M | $61.00M |
| Operating Cash Flow | $10.25B | $6.57B |
| Capital Expenditure | $23.28B | $13.37B |
| Investing Cash Flow | $-23.09B | $-13.22B |
| Debt Repayment | $13.93B | $11.07B |
| Dividends Paid | $902.00M | $465.00M |
| Financing Cash Flow | $9.38B | $5.46B |
| Net Change in Cash | $-3.46B | $-1.19B |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $3.33B | $926.00M | $9.32B | $3.45B |
| Cost of Revenue | $1.39B | $272.00M | $3.87B | $937.00M |
| Operating Expenses | $2.01B | $737.00M | $5.89B | $2.28B |
| Research & Development | $53.00M | $156.00M | $292.00M | $511.00M |
| Operating Income | $1.32B | $189.00M | $3.44B | $1.17B |
| Interest Expense | $421.00M | $128.00M | $1.01B | $467.00M |
| Other Income/Expense | $-683.00M | $-561.00M | $-1.54B | $-224.00M |
| Income Before Tax | $637.00M | $-372.00M | $1.90B | $945.00M |
| Income Tax Expense | $87.00M | $-78.00M | $354.00M | $189.00M |
| Net Income | $550.00M | $-294.00M | $1.54B | $756.00M |
| Basic EPS | 0.18 | -0.15 | 0.49 | 0.26 |
| Diluted EPS | 0.16 | -0.15 | 0.45 | 0.23 |
| Basic Shares Outstanding | $2.43B | $2.35B | $2.42B | $2.35B |
| Diluted Shares Outstanding | $2.64B | $2.35B | $2.64B | $2.58B |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $1.88B | $3.61B |
| Accounts Receivable | $633.00M | $364.00M |
| Inventory | $227.00M | $171.00M |
| Other Current Assets | $95.00M | $93.00M |
| Total Current Assets | $3.26B | $4.56B |
| Other Non-current Assets | $580.00M | $952.00M |
| Total Assets | $50.08B | $43.49B |
| Accounts Payable | $947.00M | $1.54B |
| Accrued Liabilities | $2.12B | $1.82B |
| Total Current Liabilities | $3.92B | $3.54B |
| Long-term Debt | $31.74B | $29.09B |
| Deferred Tax Liabilities | $2.02B | $1.64B |
| Other Non-current Liabilities | $860.00M | $794.00M |
| Total Liabilities | $39.26B | $35.59B |
| Retained Earnings | $3.69B | $2.61B |
| Total Stockholders Equity | $5.69B | $2.90B |
| Total Liabilities & Equity | $50.08B | $43.49B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $550.00M | $-294.00M | $1.54B | $756.00M |
| Depreciation & Amortization | $218.00M | $89.00M | $701.00M | $229.00M |
| Stock-based Compensation | - | - | $34.00M | $18.00M |
| Change in Receivables | - | - | $279.00M | $-169.00M |
| Change in Inventory | - | - | $56.00M | $129.00M |
| Operating Cash Flow | - | - | $4.46B | $1.48B |
| Capital Expenditure | - | - | $9.74B | $10.06B |
| Investing Cash Flow | - | - | $-9.58B | $-10.44B |
| Debt Repayment | - | - | $7.70B | $859.00M |
| Dividends Paid | - | - | $423.00M | $83.00M |
| Financing Cash Flow | - | - | $4.05B | $8.72B |
| Net Change in Cash | - | - | $-1.07B | $-237.00M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.